-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OYFSYS1u8GCajxhKLSQ646zIWKnwf1z4UC9+uuiw4v9yq9nXRh9aIe9ik2xAkCrT rsLLBwf/UTfIzWiQFsh7rQ== 0000950150-02-000849.txt : 20020904 0000950150-02-000849.hdr.sgml : 20020904 20020904164812 ACCESSION NUMBER: 0000950150-02-000849 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020904 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHAD THERAPEUTICS INC CENTRAL INDEX KEY: 0000713492 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 953792700 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-12214 FILM NUMBER: 02756715 BUSINESS ADDRESS: STREET 1: 21622 PLUMMER STREET CITY: CHATSWORTH STATE: CA ZIP: 91311 BUSINESS PHONE: 8188820883 MAIL ADDRESS: STREET 1: 21622 PLUMMER STREET CITY: CHATSWORTH STATE: CA ZIP: 91311 DEFA14A 1 a84146d3defa14a.htm DEFINITIVE ADDITIONAL MATERIAL Chad Therapeutics, Inc.
 

SCHEDULE 14A INFORMATION

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934

(AMENDMENT NO.___)

Filed by the Registrant [X]

Filed by a Party other than the Registrant [   ]

Check the appropriate box:

     
[   ]   Preliminary Proxy Statement
[   ]   Definitive Proxy Statement
[   ]   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[X]   Definitive Additional Materials
[   ]   Soliciting Material Pursuant to sec. 240.14a-11(c) or sec. 240.14a-12

 

CHAD THERAPEUTICS, INC.


(Name of Registrant as Specified In Its Charter)

 


(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

         
[X]   Fee not required.
[   ]   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
    (1)   Title of each class of securities to which transaction applies:


    (2)   Aggregate number of securities to which transaction applies:


    (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):


    (4)   Proposed maximum aggregate value of transaction:


    (5)   Total fee paid:


[   ]   Fee paid previously with preliminary materials.
[   ]   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
    (1)   Amount Previously Paid:


    (2)   Form, Schedule or Registration Statement No.:


    (3)   Filing Party:


    (4)   Date Filed:



 

Dear Shareholder:

Thank you for sending in your WHITE proxy card.

To avoid any possible dispute as to the validity of your proxy, for the reason(s) stated below, we are requesting you to sign, date and mail the enclosed new WHITE proxy with the correction indicated below. The new proxy will automatically revoke any previous proxy when it is returned to us in the postage-paid envelope provided for your convenience.

o      Your previous proxy was unsigned. (If signing as attorney, executor, administrator, corporate officer, trustee or guardian, please give your full title as such.)
 
o      Your previous proxy was undated. (Please date, sign and return the new proxy in the enclosed envelope.)
 
o      Your previous proxy, as signed, did not conform to the name shown on the proxy. (Please sign and date the new proxy exactly as your name appears on the proxy card, including your title if signing other than in an individual capacity.)
 
o      Your previous proxy omitted your title or authority. (If signing as attorney, executor, administrator, corporate officer, trustee or guardian, please give your full title as such.)
 
o      Your previous proxy was not signed by all joint owners. (If shares are registered in the name of more than one person, each such person should sign the proxy. If a joint tenant is deceased, please indicate that you are the surviving joint owner.)
 
o      Other
      

Please sign, date and return the enclosed WHITE proxy immediately so that your shares may be represented at the meeting. Your continued support is greatly appreciated.

If you have any questions or problems, please feel free to call our proxy solicitor, Morrow & Co., Inc., at 1-800-654-2468 (toll free).

Thank You,

Chad Therapeutics, Inc.

-----END PRIVACY-ENHANCED MESSAGE-----